Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Small
Paul K Keith
Harold Kim

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 29, 2018
Allergic rhinitisPeter Small, Paul K Keith, Harold Kim
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 15, 2011
Allergic rhinitisPeter Small, Harold Kim
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 28, 2024
Allergic rhinitisLana Rosenfield, Paul K Keith, Jaclyn Quirt, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 23, 2023
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world studyPaul K Keith, Juthaporn Cowan, Amin Kanani, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 7, 2022
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world studyPaul K Keith, Juthaporn Cowan, Amin Kanani, et al.
The Indian Journal of Medical Research|July 10, 2012
Why India should become a global leader in high-quality, affordable TB diagnosticsPeter Small
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 8, 2024
Focused allergic rhinitis practice parameter for CanadaAnne K Ellis, Victoria Cook, Paul K Keith, et al.
Clinical Therapeutics|June 20, 2007
Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trialPaul K Keith, George Luciuk
Clinical Allergy and Immunology|December 13, 2006
Nonallergic rhinitis with eosinophilia syndrome and related disordersAnne K Ellis, Paul K Keith
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 29, 2018
Allergic rhinitisPeter Small, Paul K Keith, Harold Kim
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 15, 2011
Allergic rhinitisPeter Small, Harold Kim
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 28, 2024
Allergic rhinitisLana Rosenfield, Paul K Keith, Jaclyn Quirt, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 23, 2023
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world studyPaul K Keith, Juthaporn Cowan, Amin Kanani, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 7, 2022
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world studyPaul K Keith, Juthaporn Cowan, Amin Kanani, et al.
The Indian Journal of Medical Research|July 10, 2012
Why India should become a global leader in high-quality, affordable TB diagnosticsPeter Small
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 8, 2024
Focused allergic rhinitis practice parameter for CanadaAnne K Ellis, Victoria Cook, Paul K Keith, et al.
Clinical Therapeutics|June 20, 2007
Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trialPaul K Keith, George Luciuk
Clinical Allergy and Immunology|December 13, 2006
Nonallergic rhinitis with eosinophilia syndrome and related disordersAnne K Ellis, Paul K Keith
Pageof 26